Hereditary mixed polyposis syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:157794OMIM:601228D12.6
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Hereditary mixed polyposis syndrome (HMPS) is a rare inherited condition characterized by the development of multiple types of polyps in the colon and rectum. Unlike other polyposis syndromes where a single polyp type predominates, individuals with HMPS develop a mixture of polyp types including hyperplastic polyps, atypical juvenile polyps, sessile serrated adenomas, and conventional adenomas (tubular, tubulovillous, or villous adenomas). This mixed histological presentation is a hallmark feature that distinguishes HMPS from other hereditary polyposis conditions such as familial adenomatous polyposis or juvenile polyposis syndrome. The condition primarily affects the gastrointestinal system, specifically the large bowel. Polyps typically develop during adulthood and can number from a few to several dozen. A major concern with HMPS is the significantly increased risk of colorectal cancer if the condition is left unmonitored or untreated. The syndrome has been linked to genetic alterations in the region of chromosome 10q23 and, in some families, to duplications involving the GREM1 gene (also known as the SCG2 locus on chromosome 15q13.3), which encodes a BMP antagonist. Duplication upstream of GREM1 leads to ectopic expression of this gene in colonic epithelium, disrupting normal BMP signaling and promoting polyp formation. There is currently no cure for HMPS, and management focuses on regular colonoscopic surveillance to detect and remove polyps before they progress to malignancy. The frequency and timing of surveillance colonoscopies are individualized based on polyp burden and family history. In cases where polyps are too numerous to manage endoscopically, or if cancer develops, surgical intervention such as colectomy may be necessary. Genetic counseling is recommended for affected individuals and their at-risk family members to facilitate early detection and appropriate screening strategies.

Also known as:

Clinical phenotype terms— hover any for plain English:

HematocheziaHP:0002573Hyperplastic colonic polyposisHP:0012183Colon cancerHP:0003003Adenomatous colonic polyposisHP:0005227Refractory anemiaHP:0005505Neoplasm of the gastrointestinal tractHP:0007378Juvenile colonic polyposisHP:0012198Rectal polyposisHP:0100896Colorectal polyposisHP:0200063IntussusceptionHP:0002576Adenocarcinoma of the colonHP:0040276Neoplasm of the rectumHP:0100743Thyroid carcinomaHP:0002890Duodenal adenocarcinomaHP:0006771Endometrial carcinomaHP:0012114Prostate cancerHP:0012125Gastrointestinal desmoid tumorHP:0100245
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Sep 2025Investigating the Therapeutic Efficacy of All-trans Retinoic Acid in Autism Spectrum Disorder Patients With 15q11-13 Duplication Syndrome

Second Affiliated Hospital, School of Medicine, Zhejiang University — PHASE2

TrialNOT YET RECRUITING
Apr 2024Comparative Analysis of Gremlin-1, Syndecan-4 and IL-1 Beta Levels in Gingival Crevicular Fluid Among İndividuals With Periodontal Health and Stage III Periodontitis, Considering Both Smokers and Non-Smokers, Before and After Non-Surgical Periodontal Therapy

Tugba Aydin

TrialACTIVE NOT RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Hereditary mixed polyposis syndrome.

View clinical trials →

No actively recruiting trials found for Hereditary mixed polyposis syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Hereditary mixed polyposis syndrome community →

Specialists

2 foundView all specialists →
AP
Ajay Goel, PhD
ROME, NY
Specialist
PI on 7 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Hereditary mixed polyposis syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Hereditary mixed polyposis syndromeForum →

No community posts yet. Be the first to share your experience with Hereditary mixed polyposis syndrome.

Start the conversation →

Latest news about Hereditary mixed polyposis syndrome

No recent news articles for Hereditary mixed polyposis syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Hereditary mixed polyposis syndrome

What is Hereditary mixed polyposis syndrome?

Hereditary mixed polyposis syndrome (HMPS) is a rare inherited condition characterized by the development of multiple types of polyps in the colon and rectum. Unlike other polyposis syndromes where a single polyp type predominates, individuals with HMPS develop a mixture of polyp types including hyperplastic polyps, atypical juvenile polyps, sessile serrated adenomas, and conventional adenomas (tubular, tubulovillous, or villous adenomas). This mixed histological presentation is a hallmark feature that distinguishes HMPS from other hereditary polyposis conditions such as familial adenomatous p

How is Hereditary mixed polyposis syndrome inherited?

Hereditary mixed polyposis syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Hereditary mixed polyposis syndrome typically begin?

Typical onset of Hereditary mixed polyposis syndrome is adult. Age of onset can vary across affected individuals.

Which specialists treat Hereditary mixed polyposis syndrome?

2 specialists and care centers treating Hereditary mixed polyposis syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.